Summary

Adds fentanyl-related substances and any material containing them to Schedule I of the Controlled Substances Act. The change defines "fentanyl-related substance" by listing specific structural chemical modifications that make a compound fall under the new rule, and it applies immediately (effective one day after enactment). The result is that those substances will be treated as Schedule I drugs for possession, manufacture, distribution, and prosecution purposes. The change affects law enforcement and prosecutors, people who use or sell illicit fentanyl analogs, and researchers or manufacturers who work with fentanyl-like compounds because Schedule I status imposes strict controls and licensing requirements.

Key Points

• Makes any material containing a defined "fentanyl-related substance" a Schedule I controlled substance.
• Defines fentanyl-related substances by specific structural changes to the fentanyl molecule (five enumerated modification types).
• Covers mixtures and materials that contain fentanyl-related substances, not only pure compounds.
• Becomes effective one day after enactment, creating near-immediate legal effect.
• Increases enforcement and criminal exposure for possession, manufacture, and distribution of these analogs.
• Researchers and legitimate manufacturers working with fentanyl-like compounds will face Schedule I restrictions and registration requirements.
• Aims to address emerging fentanyl analogs by using a structural definition rather than a list of individual substances.